Pharmafile Logo
Pharmafocus logo
Advanced Search

fines

Showing 4 posts of 4 posts found.

Teva image

Teva under investigation for marketing practices

February 12, 2014
Sales and Marketing Azilect, Copaxone, Teva, fines, generics

Teva Pharmaceuticals is under investigation by US authorities for sales and marketing activity around two of its drugs – including …

News
Ranbaxy image

Ranbaxy quality issues hit sixth plant; seeks Diovan workaround

January 20, 2014
Manufacturing and Production FDA, Ranbaxy, fines, manufacturing

Yet another plant operated by India’s Ranbaxy has been held up by US Food and Drug Administration over quality deficiencies, …

News

€16 million fines for J&J and Novartis

December 12, 2013
Medical Communications, Sales and Marketing EU, J&J, JJ, Novartis, Sandoz, fentanyl, fines

The European Commission has slapped multi-million euro fines on Johnson & Johnson and Novartis for what it says were ‘shocking’ …

News
Johnson and Johnson image

J&J ‘to pay out $4 billion’ in fresh legal case

November 14, 2013
Sales and Marketing J&J, JJ, Risperdal, fines, hip replacement

Johnson & Johnson is set to pay up to $4 billion to settle thousands of legal cases related to patients …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026